Drug Type Prophylactic vaccine, mRNA vaccine |
Synonyms pancoronavirus mRNA vaccine (BioNet) |
Target |
Action inhibitors |
Mechanism SARS-CoV-2 S protein inhibitors(Coronavirus spike glycoprotein inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
COVID-19 | Discovery | United States | - | |
COVID-19 | Discovery | United States | - | |
COVID-19 | Discovery | United States | - | |
COVID-19 | Discovery | United States | - | |
COVID-19 | Discovery | South Korea | - | |
COVID-19 | Discovery | Thailand | - | |
COVID-19 | Discovery | Thailand | - |